Pfizer hails Ireland as ‘industrial powerhouse’ in life sciences
Albert Bourla, chief executive of US pharma giant, accepts IDA Ireland’s Special Recognition Award on behalf of the company
Albert Bourla, chief executive of US pharma giant, accepts IDA Ireland’s Special Recognition Award on behalf of the company
European health officials have advocated portfolio diversity to help fight different variants
Interim results from its clinical trial showed the jab is safe and highly effective, company said
Vaccine and Covid pill account for half of sales in first quarter of the year
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages
Health experts call for new jabs that better protect against coronavirus transmission
Third vaccine dose as effective as second shot was in fighting original virus, study finds
New jab for Omicron variant of coronavirus being developed, Dr Albert Bourla says
Moderna chief warns existing vaccines will struggle with latest coronavirus variant
Tablet has potential to avoid nine of 10 hospitalisations with virus, says pharma giant
US employers increasingly seeking proof of full vaccination from staff and customers
Officials hope move will convince more unvaccinated Americans shot is safe and effective
The pharma boss on the group's Covid jab and his exchanges with Trump
German company announces plans to test its efficacy in children under 12 and pregnant women
Deal struck as EU worried about supplies and side effects of other vaccines
Shots will be distributed to 92 lower-income countries through COVAX programme
Cantillon: Balancing costs of research and needs of poorer countries is a challenge
Annual revaccinations, similar to flu shots, possible as virus variants emerge
Johnson & Johnson assures on production targets despite ruined batch
World round-up: Argentinian minister told to resign after organising vaccine for journalist
Pharma group raises forecasts on back of J&J rival’s efficacy and AstraZeneca woes
PM says deal agreed with Pfizer-BioNTech for vaccine delivery as harder lockdown begins
Country’s move to rapidly inoculate population helped to change public mood
Vaccine could begin roll-out from early next week
Companies hold out prospect of December deliveries
Business Today: the best news, analysis and comment from The Irish Times business desk
Company preparing to submit data to the US regulator – Food and Drug Administration
Cantillon: Albert Bourla sale of shares on day of vaccine announcement entirely legitimate
Deliveries expected to begin by the end of the year, subject to regulatory approval
Professor Luke O’Neill believes data is promising and treatments are getting better
Company now a frontrunner in coronavirus vaccine race
Albert Bourla said he would never submit vaccine for authorisation before it was safe
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices